UW Medicine says the newly approved mRNA flu vaccine, mFLUSIVA, is about 30% more effective than traditional shots for adults 50 and older.
UW Medicine says the newly approved mRNA flu vaccine, mFLUSIVA, is about 30% more effective than traditional shots for adults 50 and older.